An observational study in Premature Birth, sponsored by University of Minnesota. Completed at 1 site in United States. Open to participants aged Up to 2 Years. Per ClinicalTrials.gov, last updated 2025-01-27.
Sponsored by University of Minnesota · Observational
This study is looking at using a self-contained pH device that will assist in confirming placement of a nasogastric or orogastric tube placed in the stomach of hospitalized infants.
2,553 studies on the registry are indexed under Premature Birth; 498 are open to participants now.
This study's enrollment of 12 is below the median of 112 across 777 observational studies indexed under Premature Birth.
Browse Premature Birth studies →University of Minnesota is the lead sponsor of 1,184 studies on the registry; 195 are open to participants now.
Of its 132 completed or terminated interventional studies of FDA-regulated products, 91 (69%) have results posted.
Counted across the registry records on this site, refreshed daily.
Infants admitted to the University of Minnesota Masonic Children's Hospital neonatal intensive care unit.
Exclusion Criteria:
Infants admitted to the University of Minnesota Masonic Children's Hospital neonatal intensive care unit.
Device: nasogastric tube placement pH confirmation device
Each participation will get the contents tested by the novel device and the standard of care procedure.
PH reading comparison
Comparing the accuracy of the novel NG/OG tube placement device pH reading to the standard pH testing method.
Time frame: baseline
This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Minnesota